To ascertain that DTX3 affected the expression of E2F1 in CRC cells, we treated DTX3 KO cells with or without PD 0332991, an agent that shows a potent inhibitory effect on the transcription of E2F1. Here, DTX3 is linked to colorectal carcinoma.